F. David Tingley

Varenicline:  An α4β2 Nicotinic Receptor Partial Agonist for Smoking Cessation

Jotham W. Coe, Paige R. Brooks, Michael G. Vetelino et al. · Journal of Medicinal Chemistry · 2005 · 933 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

Hans Rollema, Leslie K. Chambers, J.W. Coe et al. · Neuropharmacology · 2006 · 535 citations

Public Health, Pharmacology, Pharmacotherapy +14

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

David W. Schulz, Robert S. Mansbach, Jeffrey Sprouse et al. · Proceedings of the National Academy of Sciences · 1996 · 379 citations

Medicine, Neuroscience, Pharmacology +17

Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia

C J Schmidt, Douglas S. Chapin, J. Cianfrogna et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 284 citations

Medicine, Neuroscience, Pharmacology +13

Phosphodiesterase 9A Regulates Central cGMP and Modulates Responses to Cholinergic and Monoaminergic Perturbation In Vivo

Robin J. Kleiman, Douglas S. Chapin, Curt Christoffersen et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 80 citations

Life Sciences, Neuroscience, Pharmacology +17